Has James McKinsey, MD received payments from drug or device companies?

Yes. Drug and device makers reported $750,171 in general payments to James McKinsey, MD across 1,166 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James McKinsey, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James McKinsey, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James McKinsey, MD

Vascular Surgery · New York, NYNPI 1104997444

Payments from drug & device makers

$750,171in general payments, 2019–2025

Across 1,166 payments — averaging $643.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Bolton Medical Inc$478K
Endologix LLC$64K
Cook Research Incorporated$48K
Medtronic$47K
M.a. Med Alliance S.A.$28K
Abbott$24K
plus $60K from 27 others

$1,200in research payments, 2019–2025

Across 1 payment — averaging $1200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Cook Research Incorporated$1K

What the payments were for

Consulting fees$146,27024%
Speaking & faculty fees$199,69032%
Grants$2740%
Travel & lodging$35,9086%
Food & beverage$62,00810%
Education$172,32528%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Bolton Medical Inc	475	$477,753
Endologix LLC	83	$63,702
Cook Research Incorporated	44	$48,248
Medtronic(2 entities)	117	$47,384
M.a. Med Alliance S.A.	4	$28,459
Abbott	40	$24,404
W. L. Gore & Associates, Inc.	86	$18,989
Cook Incorporated	13	$16,221
Cook Medical LLC	128	$6,934
Shockwave Medical, Inc	8	$4,451
Silk Road Medical, Inc.	18	$2,817
Philips North America LLC	11	$2,737
Boston Scientific	97	$2,533
Penumbra, Inc.	9	$1,945
Artivion, Inc.	2	$487
Surmodics, Inc.	3	$441
Bard Peripheral Vascular, Inc.	4	$413
Veryan Medical Incorporated	2	$326
Inari Medical, Inc.	2	$316
Viz.ai, Inc.	1	$224
Heartflow, Inc.	1	$200
Cagent Vascular Inc	1	$194
Biotronik Inc.	2	$180
Avinger Inc.	2	$173
Shape Memory Medical Inc.	1	$147
Asahi Intecc USA, Inc.	1	$118
Atrium Medical Corporation	2	$108
Angiodynamics, Inc.	1	$103
Johnson & Johnson	4	$52
Mimedx Group, Inc.	1	$46
KCI USA, Inc.	1	$29
Lemaitre Vascular, Inc.	1	$20
Cardiva Medical, Inc.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Relay Grafts$178,628
Grafts$100,036
TREO ABDOMINAL STENT-GRAFT SYSTEM$90,510
Relay Plus$58,530
RELAY THORACIC STENT-GRAFT WITH PLUS DELIVERY SYSTEM$38,657
IN.PACT Admiral$16,081
Omnilink Elite vascular stent system$12,217
ENDURANT IIS$11,810
TurboHawk$10,280
GORE TAG Thoracic Branch Endoprosthesis$8,515
Cook Medical Zenith$6,505
Product in Development$5,610
Xience V coronary stent system$5,362
Zenith$4,237
Cook Medical Aortic Intervention$3,804
Supera peripheral stent system$3,212
Cook Medical AFEN$3,000
Alto Abdominal Stent Graft System$2,972
ENROUTE Transcarotid Neuroprotection System$2,819
TAG Thoracic Endoprosthesis$2,096

How this compares

$750,171 in reported general payments places this provider in the 95th percentile of 405 vascular surgery providers in New York.

See all vascular surgery providers in New York →

Medicare billing

Part B allowed, 2024

$234,989

Medicare patients

255

Services billed

1,029

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in New York

Gary GelbfishNew York$1.9M
John LantisNew York$1.4M
Brian DerubertisNew York$1M
Thomas MaldonadoNew York$1M
Peter FariesNew York$639K
Virendra PatelNew York$590K
Rami TadrosNew York$351K
Ajit RaoNew York$329K
Todd BerlandNew York$328K
Karan GargNew York$308K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →